Sort
16,300 grants matching “fatty liver disease”
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging
$560,737Joseph A. Baur · University Of Pennsylvania · R01 · FY2021 · DK
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging
$560,737Joseph A. Baur · University Of Pennsylvania · R01 · FY2022 · DK
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging
$560,737Joseph A. Baur · University Of Pennsylvania · R01 · FY2020 · DK
Genetic and Metabolic Basis of Familial Lipodystrophies
$560,704Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2015 · DK
Lipid biosignatures of drug addiction
$560,558Daniele Piomelli · University Of California-Irvine · RC2 · FY2009 · DA
Epigenetic markers of severity in nonalcoholic fatty liver disease
$560,485Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2018 · DK
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$560,483Patrice Mimche · University Of Utah · R01 · FY2023 · DK
Insulin Regulation of Hepatic Function via Zone-Specific Transcriptional Programs
$560,465Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2022 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$560,240Marisa Wong Medina · University Of California, San Francisco · R01 · FY2023 · DK
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.
$560,037Debanjan Dhar · University Of California, San Diego · R01 · FY2023 · DK
Nuclear ATP citrate lyase and ischemia/reperfusion injury in steatotic liver
$559,993Randy J. Seeley · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Genetic Architecture of Adiposity in Multiple Large Cohorts
$559,962Ingrid Bernadette Borecki · Washington University · R01 · FY2013 · DK
Quantitative and functional analysis of brown fat nutrient fluxes in vivo and its role in organ metabolite exchange
$559,882David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · DK
The Gut Microbiota and Graft versus Host Disease (GVHD)
$559,777David Neal Fredricks · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Jagged-Notch signaling in NASH/fibrosis
$559,719Utpal Pajvani · Columbia University Health Sciences · R01 · FY2024 · DK
Notch Signaling in the Adult Lymphatic Vasculature
$559,718Carrie J. Shawber · Columbia University Health Sciences · R01 · FY2024 · HL
Host-microbiome interactions shape the metabolic effects of ketogenic diets
$559,712Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2021 · DK
RNA modification in cardiometabolic disease
$559,709Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · DK
RNA modification in cardiometabolic disease
$559,709Tamer Sallam · University Of California Los Angeles · R01 · FY2022 · DK
RNA modification in cardiometabolic disease
$559,709Tamer Sallam · University Of California Los Angeles · R01 · FY2023 · DK
RNA modification in cardiometabolic disease
$559,709Tamer Sallam · University Of California Los Angeles · R01 · FY2025 · DK
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
$559,654Samuel Klein · Washington University · R01 · FY2007 · DK
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$559,560Marisa Wong Medina · University Of California, San Francisco · R01 · FY2021 · DK
In vivo HTS assay for novel modulators of Apolipoprotein B
$559,496Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2019 · DK
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver
$559,301Qing Miao · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2025 · DK